US$ 22.19
bpc 157 trial BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded Overall, 14 of 16 patients
Description
Screening average-risk adults for vitamin B12 deficiency is not recommended
Purity: 99% (HPLC)

The central concern is not legitimate peptide medicine, but consumer experimentation with products of uncertain identity, purity, potency, sterility, and safety

Advanced peptide formulations

Supplied from our UK clinic, we only use premium, pharmaceutical grade methlycobalamin B12 manufactured in Germany

Some of our patients can only be treated with maneuvering without any drug."
